NCT06290934: An ongoing trial by Gilead Sciences
This trial is ongoing. It must report results 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06290934 |
|---|---|
| Title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 27, 2024 |
| Completion date | March 4, 2026 |
| Required reporting date | March 4, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |